普罗托实验室
PRLB
85.65
-1.76
-2.01%
普罗托实验室
US · PRLB
#2685 按市值排名
上市于 1970
85.65
-1.76
-2.01%
实时 - 追踪5344个代码 - 心跳于103秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例上升了0.3个百分点。
机构持股
- 机构持股比例
- 95.41% +0.29pp
- 机构数量
- 333 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund82.12%
Hedge Fund7.32%
Public Company2.25%
Private Company1.21%
Government Pension Fund1.16%
Individual/Insider1.10%
Insurance Company0.90%
Bank/Investment Bank0.25%
Other3.61%
主要股东 截至 2026-06-30
BlackRock
16.29% · 3.90M 股
Disciplined Growth Investors, Inc.
9.95% · 2.38M 股
Vanguard Portfolio Management, LLC
6.69% · 1.60M 股
Vanguard Capital Management, LLC
5.07% · 1.21M 股
Dimensional Fund Advisors
4.82% · 1.15M 股
State Street Global Advisors
4.76% · 1.14M 股
American Capital Management, Inc.
2.59% · 619.85K 股
Geode Capital Management, LLC
2.57% · 614.03K 股
Renaissance Technologies Corp.
1.96% · 469.25K 股
FMR
1.85% · 442.34K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 28次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Robert Bodor | Chief Executive Officer | 0.23% |
| Rainer Gawlick | Independent Chairperson | 0.19% |
| Sven Wehrwein | Lead Independent Director | 0.14% |
| Daniel Schumacher | Chief Financial Officer | 0.10% |
| Archie Black | Independent Director | 0.09% |
| Donald Krantz | Independent Director | 0.09% |
| Sujeet Chand | Independent Director | 0.09% |
| Michael Kenison | Chief Operating Officer | 0.08% |
| Stacy Greiner | Independent Director | 0.07% |
| Suresh Krishna | Chief Executive Officer | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-24 | Michael Kenison | Chief Operating Officer | Intent to Sell (Form 144) | -1,143 | $95.80 |
| 2026-09-23 | Daniel Schumacher | Chief Financial Officer | Automatic Disposition | -5,000 | $95.32 |
| 2026-09-23 | Michael Kenison | Chief Operating Officer | Intent to Sell (Form 144) | -1,800 | $95.85 |
| 2026-09-16 | Daniel Schumacher | Chief Financial Officer | Automatic Disposition | -5,000 | $85.00–85.21 |
| 2026-09-16 | Daniel Schumacher | Chief Financial Officer | Intent to Sell (Form 144) | -4,900 | $83.24 |
| 2026-09-15 | Daniel Schumacher | Chief Financial Officer | Intent to Sell (Form 144) | -100 | $79.09 |
| 2026-08-03 | Michael Kenison | Chief Operating Officer | Intent to Sell (Form 144) | -10,753 | $88.14 |
| 2026-06-01 | Sven Wehrwein | Lead Independent Director | Open Market Disposition | -2,000 | $76.91–78.38 |
| 2026-05-31 | Sven Wehrwein | Lead Independent Director | Intent to Sell (Form 144) | -2,000 | $75.95 |
| 2026-05-22 | Suresh Krishna | Chief Executive Officer | Sale to Issuer | -1,247 | $71.36 |
| 2026-05-19 | Daniel Schumacher | Chief Financial Officer | Sale to Issuer | -255 | $71.13 |
| 2026-05-19 | Bernardo Parlange | Chief Commercial Officer | Other Acquisition | +2,109 | -- |
| 2026-05-19 | Bernardo Parlange | Chief Commercial Officer | Other Derivative Acquisition | +3,789 | $71.13 |
| 2026-05-18 | Sven Wehrwein | Lead Independent Director | Other Acquisition | +2,210 | -- |
| 2026-05-18 | Archie Black | Independent Director | Other Acquisition | +2,210 | -- |
| 2026-05-18 | Donald Krantz | Independent Director | Other Acquisition | +2,210 | -- |
| 2026-05-18 | Rainer Gawlick | Independent Chairperson | Other Acquisition | +2,210 | -- |
| 2026-05-18 | Moonhie Chin | Independent Director | Other Acquisition | +2,210 | -- |
| 2026-05-18 | Sujeet Chand | Independent Director | Other Acquisition | +2,210 | -- |
| 2026-05-11 | Michael Kenison | Chief Operating Officer | Derivative Exercise and Sale | -14,960 | $33.52–70.26 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
普罗托实验室 讨论区 0 条评论